Hospitals | January 29, 2022
Sparsh hospital opens multi-organ transplant centre in Bengaluru
The new centre will comprise a team of 50 highly experienced specialists
The new centre will comprise a team of 50 highly experienced specialists
The primary objective of the ongoing trial is to determine whether ambrisentan can prevent the progression to respiratory failure and reduce the need for mechanical ventilation, among others
The submission to the US FDA has been initiated and they intend to file these data with the European Medicines Agency and other regulatory bodies in the coming weeks
The data suggest that a booster dose given within 6 to 12 months after the second dose may help maintain a high level of protection against COVID-19.
Subscribe To Our Newsletter & Stay Updated
